ST. LOUIS , April 15, 2022 /PRNewswire/ -- Centene Corporation's (NYSE: CNC) Board of Directors issued the following statement today:
The Centene Board has accepted the resignation of Leslie V. Norwalk, Esq. as a member of the Board. The Board appreciates Leslie's contribution to the Company and her service.
The Board remains committed to the continued strengthening of the Company's corporate governance practices. Since November 2021 , the company has implemented significant governance enhancements, including the appointment of five new Board members, refreshed Chairs of the Nominating and Governance, Audit, and Compensation Committees, the separation of the roles of CEO and Chairman, the appointment of a new lead independent director, and the implementation of a mandatory Board retirement age.
The entire Board is united in its support for the Company's new CEO, Sarah London , and her highly experienced, effective leadership team, all of whom are focused on executing the Company's value creation strategy.
Centene Corporation, a Fortune 25 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach – with local brands and local teams – to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Centene offers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace, the TRICARE program, and individuals in correctional facilities. The Company also serves several international markets, and contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Centene focuses on long-term growth and value creation as well as the development of its people, systems, and capabilities so that it can better serve its members, providers, local communities, and government partners.
Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, https://investors.centene.com/.
All statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue" and other similar words or expressions (and the negative thereof). Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, value creation strategy, competition, expected activities in completed and future acquisitions, including statements about the impact of our recently completed acquisition of Magellan Health (the Magellan Acquisition), other recent and future acquisitions and dispositions, investments and the adequacy of our available cash resources. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors we believe appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions. All forward-looking statements included in this press release are based on information available to us on the date hereof. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events or otherwise, after the date hereof. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; the risk that the election of new directors, changes in senior management and inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively; uncertainty as to the expected financial performance of the combined company following the recent completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; the risk that unexpected costs will be incurred in connection with the integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected, or similar risks from other acquisitions we may announce or complete from time to time; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we have recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; timing and extent of benefits from strategic value creation initiatives, including the possibility that these initiatives will not be successful, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully; restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission. This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs.
View original content:https://www.prnewswire.com/news-releases/centene-board-issues-statement-on-departure-of-board-member-301526734.html
One thing is clear in the current market conditions: it’s a time of transition. Over the past four months, the stock market has shifted from the bull run we saw in 2021 into a far more volatile state of affairs. The market dipped into correction territory in March, bounced back out in April, and now is heading down again. One result of this has been an increase in bond yields, as equities have dropped. And with the Federal Reserve embarking on a new round of interest rate hikes, that promises a
Chip stocks have lost nearly a quarter of their value this year and one analyst calls the sector 'almost uninvestable." Here's why.
On Monday billionaire Elon Musk struck a deal to buy Twitter for $44 billion, ending its run as a public company since 2013. Musk in a securities filing on April 14 had said he did not have confidence in Twitter's management. Equilar's estimate includes a year’s worth of Agrawal's base salary plus accelerated vesting of all equity awards, an Equilar spokesperson said, based on Musk’s offering price of $54.20 per share and terms in the company's recent proxy statement.
The Dow Jones rose. Twitter stock spiked as Tesla CEO Elon Musk achieved victory in his bid to take control. The Donald Trump SPAC cratered.
(Bloomberg) -- Elon Musk and Twitter Inc. reached an agreement for the world’s richest man to buy the social networking platform for $44 billion, resolving the pressing question of whether the company’s board would consent to the leveraged buyout deal.Most Read from BloombergElon Musk Lands Deal to Take Twitter Private for $44 Billion‘Weak Sauce’: Elon Musk’s 2018 Feud With Saudi Fund RevealedAnger in Japan as Ukraine Links Emperor Hirohito to Adolf HitlerMusk Nears $43 Billion Deal for Twitter
In this article, we will take a look at the 11 stocks catching investors’ eyes after earnings reports. You can skip our detailed analysis of these companies and go directly to the 5 Stocks Catching Investors’ Eyes After Earnings Reports. Notable companies from the communication services and healthcare sectors, including AT&T Inc. (NYSE:T), Verizon Communications […]
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
FEATURE Tesla CEO Elon Musk is irked at Bill Gates. He doesn’t see how Gates, a leading proponent of sustainable energy, could possibly sell Tesla stock short. And Musk says Gates is doing just that.
The worsening Covid-19 situation in China is weighing on stocks, with companies including Alibaba, JD.com, and NIO notching stark declines.
Donald Trump is one of the world's most famous businessmen. Now investors can throw in their lot with the former President with DWAC stock.
Oakmark Funds, an investment management firm, published its “Oakmark Fund” first quarter 2022 investor letter – a copy of which can be seen here. A return of -3% was reported by the fund for the first quarter of 2022, outperforming its benchmark, the S&P 500 Index which had a -5% return for the same period. Try […]
U.S. stocks turned higher Monday afternoon, shaking off earlier losses as concerns over an escalating COVID outbreak in China added to jitters over U.S. economic growth in the face of heightened inflation and monetary policy tightening.
The owners of JCPenney have made an offer to acquire archrival Kohl’s in a deal that could value the department-store chain at upwards of $8.6 billion, The Post has learned.
The stock market ended a volatile week on a gloomy note Friday, with the three major U.S. indexes plunging as investors got tripped up in worries like inflation and the Fed’s fight against it and fears of a hard-landing recession.
Software giant Microsoft has earned plaudits for its successful pivot from desktop computing to cloud computing. Many investors may be wondering: Is Microsoft stock a buy right now?
Cleveland integrated steelmaker Cleveland-Cliffs Inc. has seen the departure of its chief administrative officer and executive vice president of human resources, Maurice Harapiak. No reason was given for Harapiak's April 22 departure in a regulatory filing posted on Monday. Cleveland-Cliffs said it would make another filing after it finishes negotiating a separation agreement with the departed executive.
Last year, Annaly sold its commercial real estate business to investment firm Slate Asset Management for $2.33 billion.
(Bloomberg) -- Tesla Inc. shares fell Monday afternoon following news that Chief Executive Elon Musk is buying social media company Twitter Inc. in a $44 billion deal. Most Read from BloombergElon Musk Lands Deal to Take Twitter Private for $44 Billion‘Weak Sauce’: Elon Musk’s 2018 Feud With Saudi Fund RevealedAnger in Japan as Ukraine Links Emperor Hirohito to Adolf HitlerMusk Nears $43 Billion Deal for Twitter as Soon as MondayStocks Rebound Ahead of Big Tech Earnings Week: Markets WrapShares
When Elon Musk offered to buy Twitter for $43 billion 10 days ago, the platform didn’t welcome him with open arms. The Tesla and SpaceX CEO is in some ways Twitter’s biggest fan—he uses the platform to share views and news to such an extent that the US Securities and Exchange Commission stepped in to require that company lawyers help moderate his feed. Twitter initially responded with a “poison pill” defense that would dilute the value of Musk’s shares, if triggered, and make any takeover effort very expensive.
Why would the social media company reconsider the offer? Because the market might not provide a better one.